Dawson James Securities Announces the Completion of $1.0 Million Private Placement Financing for Sigma Labs, Inc.
April 12 2018 - 3:28PM
Dawson James Securities, Inc. in conjunction with Sigma Labs, Inc.,
(NASDAQ:SGLB) has closed on the sale to two purchasers in a private
placement of an aggregate of 1,000 shares of the Company’s
newly-created non-voting Series B Convertible Preferred Stock,
stated value $1,000 per share, and warrants to purchase an
aggregate of up to 750,000 shares of the Company’s common stock,
par value $0.001 per share, for an aggregate purchase price of
$1,000,000. The Series B Convertible Preferred is convertible into
1,000,000 shares of Common Stock based on a conversion price of
$1.00 per share. The Warrants are exercisable for five years
commencing six months following the closing of the private
placement at an exercise price of $1.47 per share.
The Company intends to use the net proceeds of
this offering (i) to make additional hires with metallurgical and
software expertise for the purpose of accelerating and completing
the development of tools with Signature/Solution libraries and
artificial intelligence facets that are designed to enable
sophisticated closed loop control of additive manufacturing
machines for real time quality assurance or rescue, (ii) to acquire
additional software and customer support personnel for production
implementations, and (iii) for other working capital and general
corporate purposes.
The net proceeds to Sigma Labs from this
offering are anticipated to be approximately $840,000 after
deducting placement agent commissions and other estimated offering
expenses payable by Sigma Labs.
Dawson James Securities, Inc. acted as the
exclusive placement agent for this offering, and was represented by
Schiff Hardin, LLP, Washington, DC.
This press release does not constitute an offer
to sell or a solicitation of an offer to buy, nor shall there be
any sale of these securities in any state or jurisdiction in which
such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction.
For more information regarding the private
placement, please refer to the Current Report on Form 8-K filed by
Sigma Labs on April 6th, 2018.
About Sigma Labs, Inc.
Sigma Labs, Inc. is a provider of quality
assurance software under the PrintRite3D® brand and a developer of
advanced, in-process, non-destructive quality assurance software
for commercial firms worldwide seeking productive solutions for
advanced manufacturing. For more information please visit us at
www.sigmalabsinc.com.
About Dawson James
Securities
Dawson James Securities specializes in capital
raising for small and microcap public and private growth companies
primarily in the Life Science/Health Care, Technology and Consumer
sectors and is a full service investment banking firm with
research, institutional and retail sales, and execution trading and
corporate services. Headquartered in Boca Raton, FL, Dawson James
is privately held with offices in New York, Maryland and New
Jersey. www.dawsonjames.com
Safe Harbor Statement
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995: This news release may
contain forward-looking information within the meaning of Section
27A Of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended, including
statements that include the words “believes”, “expects”,
“anticipates” or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or
achievements of the Company to differ materially from those
expressed or implied by such forward-looking statements.
Member FINRA/SIPC. For more information, please
contact:
Elise Stern, Managing Director, Head of
Capital
Marketsestern@dawsonjames.com561-208-2926
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Apr 2023 to Apr 2024